ebomi
Colour theme
Sign in
Insider · CIK 0001267959

Middleton Fred A

CIK 0001267959 Name as filed on the most recent filing

Filed as Middleton Fred A (1)· Middleton Fred A (69)

229 transaction lines · from 70 filings · filed 2004-09-08 to 2026-06-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

211 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2013-08-07 S, Open-market sale Stereotaxis, Inc.STXS 9,745, disposed Open Form 4 filing 0001289340-13-000051
2013-08-07 S, Open-market sale Stereotaxis, Inc.STXS 2,765, disposed Open Form 4 filing 0001289340-13-000051
2013-08-07 S, Open-market sale Stereotaxis, Inc.STXS 2,320, disposed Open Form 4 filing 0001289340-13-000051
2013-06-24 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 169,330, disposed Open Form 4 filing 0001104659-13-051381
2013-06-21 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 4 lines 2,041,714, disposed Open Form 4 filing 0001104659-13-051381
2013-06-20 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 1,912,273, disposed Open Form 4 filing 0001104659-13-050504
2013-06-19 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 1,440,384, disposed Open Form 4 filing 0001104659-13-050504
2013-06-18 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 872,608, disposed Open Form 4 filing 0001104659-13-050504
2013-03-19 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 2 lines 2,306,831, disposed Open Form 4 filing 0001104659-13-022694
2013-03-18 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 6 lines 4,745,234, disposed Open Form 4 filing 0001104659-13-022694
2013-03-11 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 9,721,775, disposed Open Form 4 filing 0001104659-13-029502
2013-03-07 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 8 lines 662,515, disposed Open Form 4 filing 0001104659-13-029502
2013-01-24 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 9,465,000, disposed Open Form 4 filing 0001104659-13-029501
2012-11-30 P, Open-market purchase Stereotaxis, Inc.STXS 37,271, acquired Open Form 4 filing 0001289340-12-000093
2012-05-10 P, Open-market purchase Stereotaxis, Inc.STXS Not reported Open Form 4 filing 0001289340-12-000038
2012-05-10 P, Open-market purchase Stereotaxis, Inc.STXS Not reported Open Form 4 filing 0001289340-12-000038
2011-12-20 P, Open-market purchase Endocyte IncECYT 2,913, acquired Open Form 4 filing 0001209191-11-062940
2011-12-19 P, Open-market purchase Endocyte IncECYT 75,383, acquired Open Form 4 filing 0001209191-11-062611
2011-12-16 P, Open-market purchase Endocyte IncECYT 158,000, acquired Open Form 4 filing 0001209191-11-062061
2011-11-21 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 65,000, acquired Open Form 4 filing 0001104659-11-066164
2011-09-15 P, Open-market purchase Stereotaxis, Inc.STXS 6,693, acquired Open Form 4 filing 0001289340-11-000053
2011-09-01 P, Open-market purchase Stereotaxis, Inc.STXS 23,453, acquired Open Form 4 filing 0001289340-11-000045
2011-06-14 P, Open-market purchase Stereotaxis, Inc.STXS 30,000, acquired Open Form 4 filing 0001289340-11-000030
2011-02-08 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 5 lines 1,874,999, acquired Open Form 4 filing 0001181431-11-009235
2011-02-07 P, Open-market purchase Endocyte IncECYT 2 lines 4,999,998, acquired Open Form 4 filing 0001209191-11-007952
2010-08-18 P, Open-market purchase Stereotaxis, Inc.STXS 84,500, acquired Open Form 4 filing 0000950138-10-000537
2009-08-31 P, Open-market purchase Stereotaxis, Inc.STXS 17,700, acquired Open Form 4 filing 0000950138-09-000578
2009-05-26 P, Open-market purchase Stereotaxis, Inc.STXS 68,814, acquired Open Form 4 filing 0000950138-09-000369
2009-05-22 P, Open-market purchase Stereotaxis, Inc.STXS 26,931, acquired Open Form 4 filing 0000950138-09-000369

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 117
  • Open-market sale 94
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Middleton Fred A, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001267959

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.